Skip to main content
main-content

Devices and technology

Feature content

03-01-2019 | Retinopathy | Video | Article

Diabetic retinopathy: Screening

Ophthalmologist Philip Burgess joins Clinical Diabetologist John Wilding to discuss diabetic retinopathy screening and the key role that it plays in reducing vision loss among people with diabetes (10:00).

02-19-2019 | Artificial pancreas systems | Feature | Article

What’s all the fuss about the DIY artificial pancreas?

DIY closed-loop insulin delivery has provoked controversy within the diabetes community, raising questions around patient empowerment, safety and liability, and whether the regulatory process remains fit for purpose in a technological age. medwireNews takes a look at the issues.

02-15-2019 | Patient-reported outcomes | Commentary | Article

‘Race to the bottom’ demotes patient-reported outcomes

02-15-2019 | Inpatient diabetes | Video | Article

Diabetes device use in women admitted to the maternity ward

With the use of insulin pumps and related technologies expected to increase among pregnant women with type 1 diabetes, Pratik Choudhary and Lori Berard discuss management protocols for women admitted to maternity units (4:26).

02-14-2019 | Inpatient diabetes | Video | Article

Hospital admissions for surgery or radiology in patients using diabetes devices

Pratik Choudhary and Lori Berard discuss considerations for treating diabetes device users admitted for surgical procedures and radiological investigations (11:41).

02-13-2019 | Inpatient diabetes | Video | Article

Emergency admissions for patients using diabetes devices

Lori Berard and Pratik Choudhary address situations that can lead to emergency department admissions in patients using diabetes devices and discuss management strategies tailored to this patient population (9:36).

02-11-2019 | Inpatient diabetes | Video | Article

Hospitalized patients using insulin pumps

Lori Berard and Pratik Choudhary address situations that can lead to hospital admissions in insulin pump users, and discuss what the treating clinician needs to know (8:42).

02-10-2019 | Inpatient diabetes | Video | Article

Continuous glucose monitoring devices and insulin dosing apps in hospital

Diabetologist Pratik Choudhary and Nurse Consultant Lori Berard discuss inpatient use of continuous glucose monitoring (CGM) devices and insulin dosing apps (8:14).

12-14-2018 | Risk factors | Feature | Article

Sleep duration: Waking up to a major metabolic risk factor

The effect of sleep duration on glucose regulation and cardiometabolic risk is becoming an increasingly high-profile issue. medwireNews takes a look at the latest evidence, which shows the gravity of the problem but also offers some solutions.

10-31-2018 | Flash glucose monitoring | Slideset | Collection

Outcomes of using flash glucose monitoring technology by children and young people with type 1 diabetes in a single arm study

The study outlined in this slide set showed improved time in optimal blood glucose range and greater treatment satisfaction among children and adolescents with type 1 diabetes using flash glucose monitoring compared with self-monitoring.
Source: Campbell FM, Murphy NP, Stewart C, Biester T, Kordonouri O. Pediatr Diabetes 2018; 19: 1294–1301
Funded by an educational grant from Abbott Diabetes Care

08-29-2018 | Blood glucose monitoring | Editorial | Article

The ambulatory glucose profile: What, why, and how?

Editorial Board member Lori Berard discusses how the ambulatory glucose profile is quietly revolutionizing the analysis of blood glucose and glycemic control for patients and practitioners.

07-24-2018 | Devices and technology | Editorial | Article

The right device at the right time: Optimizing the benefit

Advisory Board member Katharine Barnard scrutinizes the opinion that clinicians should be relying on glycemic outcomes when weighing the decision to prescribe a diabetes device.

06-10-2018 | Flash glucose monitoring | Slideset | Collection

Use of flash glucose-sensing technology for 12 months as a replacement for blood glucose monitoring in insulin-treated type 2 diabetes

This slide set outlines the extension phase of the REPLACE trial, which shows that the significant reductions in hypoglycemia obtained in patients with insulin-dependent type 2 diabetes after 6 months of flash glucose monitoring use were sustained over an additional 6 months.
Source: Haak T, Hanaire H, Ajjan R, Hermanns N, Riveline JP, Rayman G. Diabetes Ther 2017; 8: 573–586
Funded by an educational grant from Abbott Diabetes Care

06-10-2018 | Flash glucose monitoring | Slideset | Collection

Accuracy, user acceptability, and safety evaluation for the FreeStyle Libre flash glucose monitoring system when used by pregnant women with diabetes

This slide set describes a study of flash glucose monitoring in pregnant women with diabetes, which demonstrates clinical accuracy versus self-monitoring of blood glucose and a high level of acceptability by the patients.
​​​​​​​Source: Scott EM, Bilous RW, Kautzky-Willer A. Diabetes Technol Ther 2018; 20: 180–188
Funded by an educational grant from Abbott Diabetes Care

05-16-2018 | Devices and technology | Editorial | Article

Digital diabetology

Editorial Board member Sanjay Kalra presents his view on the march toward greater integration of digital health technologies and how traditional approaches to diabetes management are already changing.

03-28-2018 | Devices and technology | View from the clinic | Article

Managing patient expectations for glucose management via a device

As the utility and availability of devices surges, so too do patient expectations. Advisory Board member Katharine Barnard provides key consultation questions to help determine your patients’ greatest needs and obstacles.

02-12-2018 | Flash glucose monitoring | Slideset | Collection

Impact of flash glucose monitoring on hypoglycaemia in adults with type 1 diabetes managed with multiple daily injection therapy: a pre-specified subgroup analysis of the IMPACT randomised controlled trial

This slide set describes the results of a subgroup analysis of the IMPACT study, which demonstrates that the use of flash glucose technology is associated with a significant reduction in the time spent in hypoglycemia among patients with well-controlled type 1 diabetes treated with multiple daily injections.
Source: Oskarsson P, Antuna R, Geelhoed-Duijvestijn P, et al. Diabetologia 2018; 61: 539–550
Funded by an educational grant from Abbott Diabetes Care

12-20-2017 | Flash glucose monitoring | Slideset | Collection

Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial

This slide set presents trial findings showing that patients with well-controlled type 1 diabetes who undergo flash glucose testing achieve a greater reduction in the time spent in hypoglycemia over 6 months than those who carry out standard self-monitoring.
Source: Bolinder J, Antuna R, Geelhoed-Duijvestijn P, et al. Lancet 2016; 388: 2254–2263
Funded by an educational grant from Abbott Diabetes Care

12-19-2017 | Flash glucose monitoring | Slideset | Collection

Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type 2 diabetes: a multicenter, open-label randomized controlled trial

This slide set outlines the results of an open-label trial suggesting that the use of flash glucose-sensing technology results in similar changes in glycated hemoglobin over 6 months compared with standard self-monitoring among insulin-treated patients with type 2 diabetes.
Source: Haak T, Hanaire H, Ajjan R, et al. Diabetes Ther 2017; 8: 55–73
Funded by an educational grant from Abbott Diabetes Care

12-05-2017 | Insulin resistance | Editorial | Article

A pragmatic and practical guide to U500 regular insulin usage

Editorial Board member Sanjay Kalra shares his pragmatic and practical suggestions on initiating, monitoring, and titrating suitable patients on U500 regular insulin.

image credits